Lion Point Capital, LP
CIK: 0001643354Latest portfolio: $19.3M · Q4 2025
Holdings
39
Total Value
$19.3M
New Positions
15
Closed Positions
3
Top Holdings
View All 39 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | MISTMILESTONE PHARMACEUTICALS IN | 755,000 | $1.5M | 7.89% | +96K | |
| 2 | PRAXPRAXIS PRECISION MEDICINES I | 4,450 | $1.3M | 6.78% | -1,250 | |
| 3 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 67,500 | $889K | 4.60% | — | |
| 4 | FRXFENNEC PHARMACEUTICALS INC | 112,434 | $865K | 4.48% | -10,566 | |
| 5 | JSPRJASPER THERAPEUTICS INC | 465,000 | $850K | 4.40% | +66K | |
| 6 | BNTCBENITEC BIOPHARMA INC | 62,000 | $835K | 4.32% | — | |
| 7 | RPRXROYALTY PHARMA PLC | 21,400 | $826K | 4.27% | — | |
| 8 | GONGERON CORP | 578,000 | $762K | 3.94% | +78K | |
| 9 | SNDXSYNDAX PHARMACEUTICALS INC | 36,000 | $756K | 3.91% | -19,000 | |
| 10 | ARDXARDELYX INC | 128,650 | $750K | 3.88% | -34,100 | |
| 11 | CUECUE BIOPHARMA INC | 2,202,854 | $672K | 3.48% | NEW | |
| 12 | IRONDISC MEDICINE INC | 8,100 | $643K | 3.33% | -2,500 | |
| 13 | SRPTSAREPTA THERAPEUTICS INC | 28,500 | $613K | 3.17% | NEW | |
| 14 | BHVNBIOHAVEN LTD | 51,700 | $583K | 3.02% | +29K | |
| 15 | HUMAHUMACYTE INC | 500,000 | $480K | 2.48% | +417K | |
| 16 | KURAKURA ONCOLOGY INC | 46,000 | $477K | 2.47% | — | |
| 17 | MCRBSERES THERAPEUTICS INC | 31,570 | $469K | 2.43% | +4K | |
| 18 | CMPSCOMPASS PATHWAYS PLC | 58,000 | $400K | 2.07% | — | |
| 19 | DAWNDAY ONE BIOPHARMACEUTICALS I | 42,000 | $391K | 2.02% | — | |
| 20 | RGNXREGENXBIO INC | 26,600 | $383K | 1.98% | -31,150 | |
| 21 | BBIOBRIDGEBIO PHARMA INC | 5,000 | $382K | 1.98% | -8,300 | |
| 22 | MLYSMINERALYS THERAPEUTICS INC | 10,500 | $381K | 1.97% | -28,500 | |
| 23 | VTYXVENTYX BIOSCIENCES INC | 41,500 | $374K | 1.94% | NEW | |
| 24 | LNTHLANTHEUS HLDGS INC | 5,500 | $366K | 1.89% | NEW | |
| 25 | DYNDYNE THERAPEUTICS INC | 18,000 | $352K | 1.82% | NEW |
Quarterly Changes
New Positions
Sector Breakdown
Healthcare0.0% ($1.5251311889850837e+99T)
Unknown0.0% ($8.7B)
Filing History
Fund Information
Lion Point Capital, LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $19.3M across 39 holdings. The largest position is MILESTONE PHARMACEUTICALS IN (MIST), representing 7.9% of the portfolio. Compared to the previous quarter, the fund opened 15 new positions and closed 3 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.